MabVax Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch MabVax Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free (NCT01141491) | MabVax Therapeutics, Inc. | 2010-06-01 |
Track MabVax Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.